Option Care Health (OPCH) investor relations material

Strategic Positioning, Business Model, and Scale

• Operates a national network covering 96% of the U.S. population, serving over 315,000 patients with 190+ facilities and 5,000+ clinicians.

• Maintains in-network status with top 10 payers and offers over 600 therapies, with 90 full-service pharmacies and 750+ infusion chairs.

• Focuses on local responsiveness, patient-centered care, and strong relationships with payers and providers.

• Demonstrates strong cash flow generation, enabling disciplined capital allocation and ongoing investment in technology and innovation.

• Emphasizes value in post-acute care, cost effectiveness, and supporting aging-in-place trends.

Industry Trends and Market Drivers

• Aging population and complex diseases are increasing demand for home and alternate site care.

• Higher-acuity patients are shifting from inpatient to lower-cost care settings due to payor pressure.

• Pharmaceutical innovation is expanding specialty, biologic, and rare drug offerings.

• Technology adoption is improving efficiency, care coordination, and outcomes visibility.

• Policy changes emphasize value, outcomes, and cost containment in reimbursement.

Recent Performance and Operational Challenges

• Q1 was disruptive, with a significant drop in patient census for certain therapies, leading to a $175M reduction in revenue guidance at the midpoint.

• Maintained EBITDA guidance by focusing on cost reductions, procurement savings, and aligning cost structure with revenue.

• Acute, IG, and neuro business segments performed well, partially offsetting chronic inflammatory portfolio headwinds.

• Identified 26 priorities to re-accelerate growth, focusing on coverage, conversion, and convenience.

• Efforts are focused on rebuilding momentum through improved coverage, conversion, and service levels.